# Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery

> **NCT01174719** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 240 (actual)

## Conditions studied

- Valvular Heart Disease
- Coronary Artery Disease

## Interventions

- **DRUG:** volume replacement
- **DRUG:** Humanalbumin 5%
- **DRUG:** volume replacement

## Key facts

- **NCT ID:** NCT01174719
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2010-02
- **Final completion:** 2010-04
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174719, "Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01174719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*